Subscribe to RSS
DOI: 10.1055/s-2007-967989
Synthesis of Optically Active Substituted 3-Fluoropiperidines from Prolinols by Using DAST
Publication History
Publication Date:
24 January 2007 (online)
![](https://www.thieme-connect.de/media/synlett/200702/lookinside/thumbnails/10.1055-s-2007-967989-1.jpg)
Abstract
The treatment of optically active prolinols with DAST produces optically active 3-fluoropiperidines via aziridinium intermediates.
Key words
ring expansion - fluorine - rearrangements - piperidine - aziridinium
-
1a
Craig NC.Chen A.Suh KH.Klee S.Mellau GC.Winnewisser BP.Winnewisser M. J. Am. Chem. Soc. 1997, 119: 4789 -
1b
Briggs CRS.Allen MJ.O’Hagan D.Tozer DJ.Slawin AMZ.Goeta AE.Howard JAK. Org. Biomol. Chem. 2004, 2: 732 -
1c
Schuler M.O’Hagan D.Slawin AMZ. Chem. Commun. 2005, 4324 - 2
Shimizu M.Hiyama T. Angew. Chem. Int. Ed. 2005, 44: 214 ; and references therein -
3a
Kirsch P.Bremer M. Angew. Chem. Int. Ed. 2000, 39: 4217 -
3b
Vlahakis JZ.Wand MD.Lemieux RP. J. Am. Chem. Soc. 2003, 125: 6862 -
4a
Rzepa HS.O’Hagan D. Chem. Commun. 1997, 645 -
4b
Yoder NC.Kumar K. Chem. Soc. Rev. 2002, 31: 335 -
4c
Hodges JA.Raines RT. J. Am. Chem. Soc. 2003, 125: 9262 -
5a
Fried J.Sabo EF. J. Am. Chem. Soc. 1954, 76: 1455 -
5b
Bouzard D.Dicesare P.Essiz M.Jacquet JP.Kiechel JR.Remuzon P.Weber A.Oki T.Masuyoshi M.Kessler RE.Fung-Tomc J.Desiderio J. J. Med. Chem. 1990, 33: 1344 -
5c
Xu Y.Qian L.Prestwich GD. J. Org. Chem. 2003, 68: 5320 -
5d
Haffner CD.McDougald DL.Reister SM.Thompson BD.Conlee C.Fang J.Bass J.Lenhard JM.Croom D.Secosky-Chang MB.Tomaszek T.McConn D.Wells-Knecht K.Johnson PR. Bioorg. Med. Chem. Lett. 2005, 15: 5257 -
6a
Lal GS.Pez GP.Pesaresi RJ.Prozonic FM. Chem. Commun. 1999, 215 -
6b
Lal GS.Pez GP.Pesaresi RJ.Prozonic FM.Cheng HJ. J. Org. Chem. 1999, 64: 7048 -
7a
Middleton WJ. J. Org. Chem. 1975, 40: 574 -
7b
Hudlicky M. Org. React. 1988, 35: 513 - 8 For a review, see:
Singh RP.Shreeve JM. Synthesis 2002, 2561 - For examples, see:
-
9a
Rozen S.Faust Y.Ben-Yakov H. Tetrahedron Lett. 1979, 20: 1823 -
9b
Shiuey SJ.Kulesha I.Baggiolini EG.Uskokovic MR. J. Org. Chem. 1990, 55: 243 -
9c
Jeong LS.Moon HR.Yoo SJ.Lee SN.Chun MW.Lim Y.-H. Tetrahedron Lett. 1998, 39: 5201 -
9d
Boukerb A.Grée D.Laabassi M.Grée R. J. Fluorine Chem. 1998, 88: 23 -
9e
Phillips AJ.Uto Y.Wipf P.Reno MJ.Williams DR. Org. Lett. 2000, 2: 1165 -
9f
Hallett DJ.Gerhard U.Goodacre SC.Hitzel L.Sparey TJ.Thomas S.Rowley M. J. Org. Chem. 2000, 65: 4984 -
9g
Grunewald GL.Cadwell TM.Li Q.Criscione KR. J. Med. Chem. 2001, 44: 2849 -
9h
Lakshmipathi P.Grée D.Grée R. Org. Lett. 2002, 4: 451 -
9i
Vera-Ayoso Y.Borrachero P.Cabrera-Escribano F.Carmona AT.Gomez-Guillen M. Tetrahedron: Asymmetry 2004, 15: 429 -
10a
Somekh L.Shanzer A. J. Am. Chem. Soc. 1982, 104: 5836 -
10b
Gani D.Hitchcock PB.Young DW. J. Chem. Soc., Perkin Trans. 1 1985, 1363 -
10c
Furneaux RH.Gainsford GJ.Mason JM.Tyler PC. Tetrahedron 1994, 50: 2131 -
10d
Furneaux RH.Mason JM.Tyler PC. Tetrahedron Lett. 1994, 35: 3143 -
10e
Floreancig PE.Swalley SE.Trauger JW.Dervan PB. J. Am. Chem. Soc. 2000, 122: 6342 -
10f
Hook DF.Gessier F.Noti C.Kast P.Seebach D. ChemBioChem 2004, 5: 691 -
10g
Ye C.Shreeve JM. J. Fluorine Chem. 2004, 125: 1869 - For comprehensive reviews, see:
-
11a
Cossy J.Gomez Pardo D. Chemtracts: Org. Chem. 2002, 15: 579 -
11b
Cossy J.Gomez Pardo D. Targets in Heterocyclic Systems - Chemistry and Properties Vol. 6:Attanasi OA.Spinelli D. Italian Society of Chemistry; Rome, Italy: 2002. p.1 -
12a
Cossy J.Dumas C.Michel P.Gomez Pardo D. Tetrahedron Lett. 1995, 36: 549 -
12b
Cossy J.Dumas C.Gomez Pardo D. Synlett 1997, 905 -
12c
Cossy J.Dumas C.Gomez Pardo D. Bioorg. Med. Chem. Lett. 1997, 7: 1343 -
12d
Cossy J.Dumas C.Gomez Pardo D. Eur. J. Org. Chem. 1999, 1693 -
12e
Cossy J.Mirguet O.Gomez Pardo D. Synlett 2001, 1575 -
12f
Brandi A.Cicchi S.Paschetta V.Gomez Pardo D.Cossy J. Tetrahedron Lett. 2002, 43: 9357 -
12g
Déchamps I.Gomez Pardo D.Karoyan P.Cossy J. Synlett 2005, 1170 -
12h
Déchamps I.Gomez Pardo D.Cossy J. ARKIVOC 2007, (v): 38 - 14
Meng-Yang C.Chung-Yi C.Min-Ruey T.Tze-Wie T.Nein-Chen C. Synthesis 2004, 840 - 15
Heindl C.Hübner H.Gmeiner P. Tetrahedron: Asymmetry 2003, 14: 3153 - 18
Seebach D.Boes M.Naef R.Schweizer WB. J. Am. Chem. Soc. 1983, 105: 5390 - 21
Métro T.-X.Appenzeller J.Gomez Pardo D.Cossy J. Org. Lett. 2006, 8: 3509 - Benzyl and allyl neighboring groups are reported to participate in DAST reactions in the absence of internal nucleophile, for examples, see:
-
22a
Haigh D.Jefcott LJ.Magge K.McNab H. J. Chem. Soc., Perkin Trans. 1 1996, 1895 -
22b
Burnell-Curty C.Faghih R.Pagano T.Henry RF.Lartey PA. J. Org. Chem. 1996, 61: 5153
References and Notes
General Procedure for the Ring Expansion of Prolinols 1-5 and 19-23.
To a stirred solution of prolinol (0.5 mmol) in THF or CH2Cl2 (5 mL) at 0 °C, DAST (0.7 mmol) was added dropwise. After 1 h, the cooling bath was removed and the reaction mixture was stirred at r.t. for 1 h. The reaction was worked up by cooling to 0 °C followed by careful addition of a sat. NaHCO3 solution (10 mL). The mixture was extracted twice with EtOAc (30 mL). The crude product was purified by flash chromatography on silica gel using cyclohexane-Et2O (9:1) as eluant.
Compound 12: [α]D 20 -6.7 (c 0.135, CHCl3). IR (neat): 2921, 1460, 1252, 1153, 1090, 835, 776, 739, 699 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.40-7.15 (m, 5 H), 4.80 (dm, J = 47.2 Hz, 1 H), 4.06 (dddd, J = 9.5, 9.5, 4.5, 4.5 Hz, 1 H), 3.64 (d, J = 13.4 Hz, 1 H), 3.52 (d, J = 13.4 Hz, 1 H), 2.92-2.79 (m, 2 H), 2.29-1.99 (m, 3 H), 1.59-1.36 (m, 1 H), 0.83 (s, 9 H), 0,03 (s, 3 H), 0,01 (s, 3 H). 13C NMR: δ = 137.5 (s), 129.0 (d), 128.3 (d), 127.1 (d), 87.9 (dd, ¹ J C-F = 171.2 Hz), 65.1 (d), 62.3 (t), 60.2 (t), 56.0 (dt, 2 J C-F = 20.2 Hz), 38.8 (dt, 2 J C-F = 20.2 Hz), 25.8 (q), 18.1 (s), -4.8 (q). MS (EI): m/z (relative intensity) = 323 (2) [M+], 308 (3), 303 (2), 290 (2), 266 (31), 246 (4), 232 (2), 192 (3), 191 (4), 190 (3), 134 (11), 102 (2), 100 (2), 92 (9), 91 (100), 77 (3), 75 (4), 73 (10), 65 (3), 59 (3). HRMS: m/z calcd for C18H31NFOSi [MH]+: 324.2159; found: 324.2151.
17Compound 14: [α]D 20 +37.6 (c 0.35, CHCl3). IR (neat): 3069, 2930, 2856, 2800, 1588, 1471, 1427, 1360, 1154, 1105, 1027, 976, 821, 738, 698 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.65-7.58 (4 H), 7.43-7.21 (11 H), 4.83 (ddddd, J = 47.7, 5.0, 5.0, 2.5, 2.5 Hz, 1 H), 4.13 (dddd, J = 8.0, 8.0, 4.0, 4.0 Hz, 1 H), 3.50 (s, 2 H), 2.74-2.58 (m, 2 H), 2.40 (ddd, J = 29.1, 12.1, 2.0 Hz, 1 H), 2.15 (m, 1 H), 1.98 (m, 1 H), 1.67 (m, 1 H), 1.04 (s, 9 H). 13C NMR (100 MHz, CDCl3): δ = 137.6 (s), 135.7 (d), 134.2 (s), 134.0 (s), 129.7 (d), 129.6 (d), 129.0 (d), 128.2 (d), 127.7 (d), 127.6 (d), 127.1 (d), 87.7 (dd, J = 170 Hz), 66.2 (dd, J = 3 Hz), 62.2 (t), 59.6 (t), 56.3 (dt, J = 21 Hz), 38.5 (dt, J = 20 Hz), 27.0 (q), 19.2 (s). MS (EI): m/z (relative intensity) = 447 (1) [M+], 414 (2), 392 (7), 391 (27), 390 (82), 370 (4), 225 (3), 222 (3), 201 (8), 199 (10), 192 (7), 191 (6), 183 (9), 181 (6), 170 (5), 135 (7), 92 (8), 91 (100), 65 (3). HRMS: m/z calcd for C28H35NFOSi [MH]+: 448.2472; found: 448.2473.
19Compound 28: [α]D 20 +6.6 (c 0.35, CHCl3). IR (neat): 2930, 2856, 2786, 1460, 1427, 1384, 1252, 1180, 1106, 1083, 1048, 936, 888, 821, 776, 739, 700 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.67-7.63 (m, 4 H), 7.42-7.33 (m, 6 H), 4.12 (dddd, J = 10.1, 10.1, 5.0, 5.1 Hz, 1 H), 2.90-2.83 (m, 1 H), 2.79-2.73 (m, 1 H), 2.22 (s, 3 H), 2.11-2.03 (m, 1 H), 2.00-1.78 (m, 2 H), 1.63-1.51 (m, 3 H), 1.06 (s, 9 H), 0.89 (t, J = 7.5 Hz, 3 H). 13C NMR: δ = 135.7 (d), 134.1 (s), 129.7 (d), 127.6 (d), 95.1 (ds, 1 J C-F = 172 Hz), 66.4 (d), 62.3 (t), 61.7 (dt, 2 J C-F = 21.2 Hz), 45.8 (q), 41.4 (dt, 2 J C-F = 22.0 Hz), 31.4 (dt, 2 J C-F = 22.7 Hz), 27.0 (q), 19.2 (s), 7.10 (q). MS (EI): m/z (relative intensity) = 399 (2) [M+], 379 (12), 364 (9), 343 (28), 342 (100), 322 (15), 225 (7), 201 (11), 199 (13), 183 (18), 181 (10), 144 (18), 124 (30), 122 (23), 94 (11), 58 (12).
20The ee values were determined by HPLC: OJ-H, hexane, 0.3 mL/min.